1 / 27

International Trends in Erythropoietin Use in Hemodialysis Patients

Explore the evolving landscape of erythropoietin use and hemoglobin levels in hemodialysis patients worldwide through DOPPS data analysis and guidelines. This study delves into demographic parameters, mean Hgb levels, ESA doses, anemia management, and more, providing valuable insights for healthcare professionals. Discover key findings and recommendations shaping the future of patient care in hemodialysis settings.

tad-pitts
Télécharger la présentation

International Trends in Erythropoietin Use in Hemodialysis Patients

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. When Using DOPPS Slides

  2. DOPPS Slide Use Guidelines

  3. International Trends in Erythropoietin Use and Hemoglobin Levels in Hemodialysis Patients

  4. Introduction

  5. DOPPS Background (1)

  6. DOPPS Background (2)

  7. Methods (1)

  8. Methods (2)

  9. Methods (3)

  10. Table 1: Selected demographic parameters among DOPPS countries (1)

  11. Table 1: Selected demographic parameters among DOPPS countries (2)

  12. Table 1: Selected demographic parameters among DOPPS countries (3)

  13. Table 1: Selected demographic parameters among DOPPS countries (5)

  14. Table 2: Changes in mean Hgb levels and % of patients with Hgb level above 12.0 g/dL (1)

  15. Table 2: Changes in mean Hgb levels and % of patients with Hgb level above 12.0 g/dL (2)

  16. Figure 1: Mean ESA dose and Hgb level

  17. Table 3: Changes in mean ESA dose (1)

  18. Table 3: Changes in mean ESA dose (2)

  19. Table 4: Changes in percentage of patients with mean ESA dose greater than 35,000 U/weeka

  20. Table 5: Changes in mean monthly intravenous iron dose (mg/month)

  21. Table 6: Changes in median hemoglobin levels and median ESA dose (1)

  22. Table 6: Changes in median hemoglobin levels and median ESA dose (2)

  23. Table 7: Answers from DOPPS III Questionnaire Anemia Management Section

  24. Figure 2: Hemoglobin target range for adult hemodialysis patients on an ESA

  25. Conclusions

  26. Acknowledgements

More Related